Founders Financial Alliance’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
CB
Founders Financial Alliance's IBB Position: Q2 2026 in Review
Founders Financial Alliance increased its iShares Biotechnology ETF (IBB) stake by 178% in Q2 2026, buying an estimated $129K and bringing the position to 1,177 shares worth $224K. The position accounts for 0.03% of the portfolio, ranked #402.
Founders Financial Alliance first reported a position in IBB in Q1 2021 and has held it in 22 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Founders Financial Alliance held 1,177 shares of iShares Biotechnology ETF worth $224K as of Q2 2026.
- Founders Financial Alliance bought 753 iShares Biotechnology ETF shares in Q2 2026, an estimated $129K.
- iShares Biotechnology ETF made up 0.03% of Founders Financial Alliance's portfolio in Q2 2026, its #402 holding.
- Founders Financial Alliance first reported a position in iShares Biotechnology ETF in Q1 2021 and has held it in 22 quarters since.
- 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Founders Financial Alliance's 13F filing for Q2 2026, filed 4 Aug 2026.